Cargando…

Study Design Characteristics and Endpoints for Enriched Enrollment Randomized Withdrawal Trials for Chronic Pain Patients: A Systematic Review

Enriched enrollment randomized withdrawal (EERW) pain trials are designed to include only responders with considerable pain relief without unacceptable side effects into the randomized phase. There are no recommendations for primary endpoints in such trials. Our objective was to propose recommendati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kopsky, David J, Szadek, Karolina M, Schober, Patrick, Vrancken, Alexander F J E, Steegers, Monique A H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860756/ https://www.ncbi.nlm.nih.gov/pubmed/35210848 http://dx.doi.org/10.2147/JPR.S334840

Ejemplares similares

Enriched enrollment randomized double-blind placebo-controlled cross-over trial with phenytoin cream in painful chronic idiopathic axonal polyneuropathy (EPHENE): a study protocol
por: Kopsky, David J., et al.
Publicado: (2022)

Efficacy of opioids versus placebo in chronic pain: a systematic review and meta-analysis of enriched enrollment randomized withdrawal trials
por: Meske, Diana S, et al.
Publicado: (2018)

Endpoints in pediatric pain studies
por: van Dijk, Monique, et al.
Publicado: (2010)

Efficacy and tolerability of buccal buprenorphine in opioid-experienced patients with moderate to severe chronic low back pain: results of a phase 3, enriched enrollment, randomized withdrawal study
por: Gimbel, Joseph, et al.
Publicado: (2016)

Patient recruitment strategies for adaptive enrichment designs with time-to-event endpoints
por: Uozumi, Ryuji, et al.
Publicado: (2019)

Efficacy and safety of vixotrigine in idiopathic or diabetes-associated painful small fibre neuropathy (CONVEY): a phase 2 placebo-controlled enriched-enrolment randomised withdrawal study
por: Faber, Catharina G., et al.
Publicado: (2023)

Efficacy and safety of controlled-release oxycodone for the management of moderate-to-severe chronic low back pain in Japan: results of an enriched enrollment randomized withdrawal study followed by an open-label extension study
por: Kawamata, Mikito, et al.
Publicado: (2019)

Nabilone for non-motor symptoms of Parkinson’s disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study)
por: Peball, Marina, et al.
Publicado: (2019)

No Detectable Phenytoin Plasma Levels After Topical Phenytoin Cream Application in Chronic Pain: Inferences for Mechanisms of Action
por: Kopsky, David J, et al.
Publicado: (2022)

The MOBILE Study—A Phase IIa Enriched Enrollment Randomized Withdrawal Trial to Assess the Analgesic Efficacy and Safety of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Patients with Peripheral Neuropathic Pain
por: Bradford, Daniel, et al.
Publicado: (2017)

Optimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug Withdrawal
por: Annaházi, Anita, et al.
Publicado: (2015)

Use of antithrombotics at the end of life: an in-depth chart review study
por: Huisman, Bregje A.A., et al.
Publicado: (2021)

Comparison of explanatory and pragmatic design choices in a cluster-randomized hypertension trial: effects on enrollment, participant characteristics, and adherence
por: Margolis, Karen L., et al.
Publicado: (2022)

AI-based histologic scoring enables automated and reproducible assessment of enrollment criteria and endpoints in NASH clinical trials
por: Iyer, Janani S., et al.
Publicado: (2023)

IPF clinical trial design and endpoints
por: Nathan, Steven D., et al.
Publicado: (2014)

Topical phenytoin for the treatment of neuropathic pain
por: Kopsky, David J, et al.
Publicado: (2017)

The STArgardt Remofuscin Treatment Trial (STARTT): design and baseline characteristics of enrolled Stargardt patients
por: Dhooge, Patty P.A., et al.
Publicado: (2022)

Phenytoin Cream for the Treatment of Neuropathic Pain: Case Series
por: Kopsky, David J., et al.
Publicado: (2018)

Reduced withdrawal and failure rates of accelerated nursing students enrolled in pharmacology is associated with a supportive intervention
por: Doggrell, Sheila Anne, et al.
Publicado: (2016)

High-dose naloxone: Effects by late administration on pain and hyperalgesia following a human heat injury model. A randomized, double-blind, placebo-controlled, crossover trial with an enriched enrollment design
por: Springborg, Anders Deichmann, et al.
Publicado: (2020)

The evolution of and challenges in defining the clinical endpoint in tuberculosis treatment trials with non-inferiority designs
por: Phillips, Patrick PJ, et al.
Publicado: (2011)

Single-Blind Placebo-Controlled Response Test with Phenytoin 10% Cream in Neuropathic Pain Patients
por: Kopsky, David J., et al.
Publicado: (2018)

Treatment of Gleet and Sexual Neurasthenia by Means of Metallig Bougies
por: Szadek, Charles
Publicado: (1891)

Notes on the Use of Sulphur Preparations in Skin Diseases
por: Szadek, Charles
Publicado: (1891)

Treatment of Chancroid by the Potassate of Sozoiodol
por: Szadek, Charles
Publicado: (1890)

Secondary endpoints analysis in patients with estrogen receptor-positive metastatic breast cancer treated with everolimus and exemestane enrolled in Oral Care-BC
por: Nakatsukasa, Katsuhiko, et al.
Publicado: (2021)

Characteristics and Treatments of Patients Enrolled in the CHAMP‐HF Registry Compared With Patients Enrolled in the PARADIGM‐HF Trial
por: DeVore, Adam D., et al.
Publicado: (2018)

Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndrome
por: Keppel Hesselink, Jan M, et al.
Publicado: (2015)

Walking with Neuropathic Pain: Paradoxical Shift from Burden to Support?
por: Kopsky, David J., et al.
Publicado: (2015)

Is more involvement needed in the clinical trial design & endpoints?
por: Vroom, Elizabeth
Publicado: (2012)

Chronic pain, social withdrawal, and depression
por: Harris, Rebecca Arden
Publicado: (2014)

Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells
por: Keppel Hesselink, Jan M, et al.
Publicado: (2013)

Cortical plasticity as a new endpoint measurement for chronic pain
por: Zhuo, Min
Publicado: (2011)

Multimodal Stepped Care Approach Involving Topical Analgesics for Severe Intractable Neuropathic Pain in CRPS Type 1: A Case Report
por: Kopsky, David J., et al.
Publicado: (2011)

The PATCH trial: efficacy and safety of 5% lidocaine-medicated plaster for the treatment of patients with trigeminal neuralgia: a study protocol for a multicentric, double-blind, enriched enrolment randomised withdrawal, vehicle-controlled study
por: Zhao, Chunmei, et al.
Publicado: (2021)

Central Neuropathic Pain in a Patient with Multiple Sclerosis Treated Successfully with Topical Amitriptyline
por: Kopsky, David J., et al.
Publicado: (2012)

Endpoints for Lymphatic Filariasis Programs
por: Grady, Caroline A., et al.
Publicado: (2007)

Optimal experimental designs for dose–response studies with continuous endpoints
por: Holland-Letz, Tim, et al.
Publicado: (2014)

A two-stage design with two co-primary endpoints
por: Song, James X.
Publicado: (2015)

Choice of futility boundaries for group sequential designs with two endpoints
por: Schüler, Svenja, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qptcgir800mj2k31s7lto7ta5u